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Abstract
The purpose of this study was to develop and validate the Zahn-Given Recovery
Beliefs Questionnaire (RBQ). The RBQ is a formal measure designed to assess specific
underlying beliefs and expectations that relate to treatment non-adherence and recidivism in
adult psychiatric patients. A total of 100 subjects were administered the RBQ, the Beck
Hopelessness Scale (BHS), the Dysfunctional Attitudes Scale (DAS); included as well are
self and clinician-rated compliance with treatment measures. Factor analysis of the RBQ
reveals a factor structure that includes four factors: Embarrassment/ Stigma, Unrealistic
Optimism, Hopelessness/ Pessimism and Concerns About Side Effects. A total scale alpha
reliability of .82 indicates stability of the instrument. The RBQ demonstrates construct
validity as evidenced by positive correlations with the BHS and DAS, which also measure
distorted styles of thinking. Furthermore, the Pessimism/ Hopelessness factor of the RBQ
correlates positively with the BHS. Recidivists (n = 31) did not significantly differ from
non-recidivists (n = 69) on total RBQ score, although non-recidivists endorsed more
concerns related to the use of psychiatric medications as measured by the Concerns About
Side Effects Factor of the RBQ. Treatment implications and recommendations for future
research are discussed.
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Psychometric Development and Validation of the Zahn-Given Recovery Beliefs
Questionnaire In an Adult Psychiatric Sample

Introduction

Among those admitted to psychiatric hospitals are a subgroup of psychiatric patients
who are sometimes referred to as "revolving door" patients. This term refers to those patients
who have a high number of hospital admissions compared with other psychiatric patients.
Researchers have identified patients with three or more admissions within a twelve to
eighteen month period as recidivists; that is those frequently utilizing inpatient psychiatric
services. This phenomenon is frequently related to non-adherence to prescribed medication
or to treatment. Nelson, Maruish and Axler (2000) report that patients who fail to engage in
outpatient treatment, post discharge, are two times more liable to be rehospitalized than
patients who keep at least one outpatient appointment. Aggregated annual rates from this
study indicate that patients who kept their outpatient appointments had a one in ten chance of
being rehospitalized, and there was a one in four chance for those who did not. Furthermore,
Casper, Romo and Fasnacht (1991) report that 24% - 43% of patients who do not adhere to
treatment will be routinely readmitted to psychiatric facilities. Current estimates on
recidivism rates for psychiatric patients are not well documented, although it is believed that
30-60% of patients receiving medical care do not adhere to recommended treatment
(Meichenbaum & Turk, 1987).
In reviewing the research on recidivism, several explanations have been proposed.
Demographic data suggest that utilization of inpatient services tends to occur more frequently
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in patients who are male, are younger than 40 years old and have never married (Casper &
Donaldson, 1990; Green, 1988; Carpenter et al., 1985). Some researchers speculate that
recidivism is the result of housing problems, financial problems, or other psychosocial
stressors (Surber et al., 1987; Harris, Bergman, & Bachrach, 1986). These characteristics,
however, do not seem to identify or to predict readmission reliably because they are common
problems for many psychiatric patients. In fact, Goodpastor and Hare (1991) found that
fewer than 5% of hospitalized patients have any identifiable psychosocial stressors that
preceded hospitalization.
Two factors that have been consistently identified with recidivism are noncompliance with medication and aftercare, and drug or alcohol use (Owen et al., 1996;
Haywood et al., 1995; Goodpastor & Hare, 1991; Casper & Donaldson, 1990; Green, 1988;
Surber, et al., 1987; Geller, 1986; Harris, Bergman, & Bachrach, 1986; Carpenter, et al.,
1985). Therefore, it important to understand the cognitive factors underlying these behaviors
in an effort to reduce the need for frequent admissions to psychiatric facilities.
Although non-compliance is a common reason for hospitalization, many psychiatric
patients require re-admission to psychiatric facilities despite adherence to recommended
treatment. This can be the result of a an exacerbation of psychiatric symptoms caused by
specific life stressors, such as financial problems, marital problems, unemployment, chronic
medical conditions, loss of loved ones, etc. Relapse rates for major depression, for instance,
have been estimated at 50% for patients with one prior depressive episode and 80-90% for
those with two prior episodes (Delgado, 2000). Despite these numbers, the majority of
clinically depressed patients discontinue their medication within the first six months of
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treatment (Delgado, 2000). Many patients discontinue treatment because of specific beliefs
they have about their depression or its treatment.
Patients’ beliefs about the recommended treatment itself are considered to be
important in understanding treatment non-adherence and recidivism. Using a cognitive
behavioral perspective based on Beck’s (1976) Cognitive Therapy for depression, clinicians
are able to formulate a meaningful conceptual model for understanding treatment nonadherence. One premise of Cognitive Therapy is that thoughts or interpretations of events
influence feelings and behaviors. Beck (1976) observed that the thoughts of depressed
patients were often distorted or exaggerated. These errors in logic or cognitive distortions
have been seen in patients with a variety of clinical disorders (see Table 1). Cognitive
Therapy asserts that modification of distorted or irrational beliefs can result in improvements
in one’s mood and changes of behavior.
In understanding treatment non-adherence, it is important to identify quickly the
beliefs that may influence patients to discontinue treatment. The decision to stop treatment
may result from distorted beliefs patients have about the treatment itself. For example, some
patients may think, “Taking medication for my depression means I am weak.”(labeling) or “I
should be able to handle this on my own” (should statement). Others may think,
“Medications that have side effects can’t be good for you” (overgeneralization). Identifying,
evaluating and modifying these types of distorted beliefs is believed to be an important
process in enhancing treatment adherence by allowing patients to have more realistic
expectations regarding psychiatric treatment.
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Table 1

Commonly Observed Cognitive Distortions
Cognitive Distortion

Definition

Dichotomous thinking

Things are seen in terms of two mutually exclusive categories with
no “shades of gray” in between.

Overgeneralization

A specific event is seen as being characteristic of life in general
rather than as being one event among many.

Selective abstraction

One aspect of a complex situation is the focus of attention, and other
relevant aspects of the situation are ignored.

Disqualifying the positive

Positive experiences that would conflict with the individual’s
negative views are discounted, declaring that they “don’t count.”

Mind reading

The individual assumes that others are reacting negatively without
evidence that this is the case.

Fortune telling

The individual reacts as though his or her negative expectations
about future events are established facts.

Catastrophizing

Negative events that might occur are treated as intolerable
catastrophes rather than being seen in perspective.

Minimization

Positive characteristics or experiences are treated as real but
insignificant.

Emotional reasoning

Assuming that emotional reactions necessarily reflect the true
situation.

“Should” statements

The use of should and have-to statements to provide motivation or
control behavior.

Labeling

Attaching a global label to oneself rather than referring to specific
events or actions.
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Personalization

Assuming that one is the cause of a particular external event when,
in fact, other factors are responsible.

Note. Adapted from Freeman, Pretzer, Fleming & Simon (1990). Clinical applications of cognitive
therapy (p. 5). New York: Plenum Press.

Statement of the Problem

There is little research exploring the attitudes and beliefs of psychiatric patients that
lead to noncompliance with treatment. Such beliefs about illness and the process of recovery
are believed to be important in understanding noncompliance with aftercare. Meichenbaum
and Turk (1987) discussed the importance of assessing patient beliefs in facilitating treatment
adherence. They contended that non-adherence may be the result of distorted thinking,
misconceptions, lack of understanding, faulty information and cultural myths. Additionally,
fear, guilt, shame, and “paralysis of will” often contribute to non-adherence (Meichenbaum
and Turk, 1987). Paralysis of will is a term “first used by Beck to describe extreme
depression and it was used to convey an amotivational state with severe perceived barriers to
initiating any efforts” (D. Meichenbaum, personal communication, August 2, 2003). Table 2
describes common reasons related to treatment non-adherence.
Horne (1997) identifies two types of non-adherence: unintentional and intentional
non-adherence. Unintentional non-adherence results from patients forgetting, from poor
understanding of treatment instructions, or from specific illness-related deficits (e.g.,
impaired cognitive functioning). On the other hand, intentional non-adherence results from a
"rational" decision made by patients, which is typically justified by a variety of reasons. For
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example, patients may deny the existence of a problem or minimize the fact that they have a
psychiatric condition that warrants continued treatment. They may blame others as the
source of the problem while denying any personal responsibility. Some patients may have
faulty expectations regarding the course of treatment (e.g., thinking that an anti-depressant
medication will work in a few days, or thinking that feeling better is an indication that
treatment is no longer needed, etc.). Often inpatient psychiatric patients will report that they
stopped taking their medication prior to being re-hospitalized. The reason frequently given is
that that they were feeling better so they thought that they no longer needed their medication
(e.g., "Why should I take medication if I'm feeling better?"). Such distorted beliefs and
cognitions, if made the primary focus of treatment for psychiatric recidivists, could
potentially reduce the need for readmission as the result of treatment noncompliance.

Table 2
Factors Related to Treatment Non-Adherence

Uncertainty about the efficacy of treatment
Prior experience with illness and changes in patient’s health
Expectations about symptoms, illness, health care providers, and treatment
Past experiences with health care providers
Concerns about possible side effects
Determination that costs outweigh benefits
Embarrassment about being in treatment
Pessimism or skepticism about the effectiveness of treatment
Impatience with the level of progress or the treatment process
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Competing demands that are deemed more important
Paralysis of will
Viewing treatment as interfering with future plans, relationships, self-concept or daily life
Note. Adapted from Meichenbaum & Turk, (1987). Facilitating treatment adherence: A
practitioner’s guidebook. New York & London: Plenum Press.

Theoretical Background & Related Research

The health belief model.

One theoretical construct for understanding health-related behaviors (e.g., treatment
compliance) is the Health Belief Model (HBM) (Rosenstock, 1966, 1974). The HBM
postulates that treatment compliance is related to patients' beliefs about personal vulnerability
or susceptibility to the illness, the perceived severity of the illness, beliefs about the efficacy
and benefits of treatment, and the costs associated with compliance (Rosenstock, 1966,
1974). Contemporary researchers have explored the utility of the HBM in understanding
medication compliance. For example, Budd, Hughes and Smith (1996) found that perceived
severity of the illness, personal susceptibility and benefits of treatment are related to
compliance although beliefs about the costs of treatment are not. This study also found that
insight in to one's psychiatric condition is not a significant predictor of compliance with
treatment. Similarly, other researchers have found that compliance with medication for
patients with schizophrenia is independent of level of insight (Garavan et al., 1998);others
report, however, that compliance is strongly related to attitudes to treatment and insight
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(Kemp et al., 1996). Furthermore, Meichenbaum and Turk (1987) report that knowledge
about one's illness is not significantly related to treatment adherence.

The self-regulation model.

Other researchers have postulated a “common-sense model of illness cognition”,
which represents a conceptualization of the processes involved in adapting to illness-related
threats (Leventhal, Diefenbach & Leventhal, 1992, p. 144). They postulate that treatment
adherence or non-adherence results from an interaction among representations of health
threats, emotional reactions and coping procedures. They suggest that there are two largely
independent processing systems, one comprising the objective representations of health
threats and coping procedures and the other the subjective or emotional processing system,
which is geared toward the management of emotions. Together these two processing systems
compose the self-regulation model (SRM) (Leventhal, Diefenbach & Leventhal, 1992). They
suggest that representations of the illness heavily influence health-related behavior and
coping responses. The SRM identifies representations or beliefs about illness into five
components: Identity (What caused it?), Time-line (How long will it last?), Consequences
(How has it/will it affect me?), and Cure/Control (Can it be controlled or cured?). The
authors suggest that adherence to treatment is high when both the patient and practitioner
have similar representations of the illness and agree upon treatment methods and criteria for
evaluating outcome. Conversely, adherence is low when differences in beliefs exist between
patient and practitioner.
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The working alliance & adherence.

One method for increasing adherence is to understand the importance of the
therapeutic alliance. In 1976, Edwin Bordin published a paper on the therapeutic alliance
that addressed the importance of the therapeutic relationship across all types of therapy.
Bordin believed that the concept of the alliance was generic to all forms of therapy. He
stated that the alliance involved agreement between patient and therapist, making it a more
collaborative relationship than those that others have reported (Rogers, 1951). Bordin (1976)
describes the alliance in terms of three components: agreement on goals, on tasks, and on
developing an interpersonal bond. Agreement on treatment goals consists of both short-term
and long-term expectations between patient and therapist. Bordin (1994) also states that
negotiation is an integral part in this process. The treatment goals need to be realistic and
should be mutually agreeable to both patient and therapist.
The establishment of goals is crucial in determining the effectiveness of treatment.
Goals must be measurable and realistic for patients, yet provide a focus for treatment. Once
meaningful goals have been established the therapeutic tasks are negotiated. The tasks refer
to the methods that will be employed throughout the course of treatment to help patients
achieve their goals. Bordin (1994) describes the therapeutic tasks as, "the specific activities
that the partnership will engage in to instigate or facilitate change" (p.17). This would
include such things as frequency of visits, time limits, homework, specific techniques and so
on. Bordin pointed out that the patient must understand the relevance of these tasks to their
goals in order to remain an active partner in treatment. Also, both patient and therapist must
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assume responsibility for these acts and their own behaviors as they relate to the goals of
treatment.
The third component of the working alliance is the establishment of an interpersonal
bond between patient and therapist. This bond develops out of trust, respect and a sense of
common purpose. Obviously, this can be a slow and delicate process for some patients who
have a weak capacity for forming relationships. If a bond is not formed with patients then
they may withhold important information that would otherwise be revealed. Developing a
positive working alliance allows patients to be committed to treatment while enhancing
adherence and treatment efficacy (Bordin, 1976; Horvath & Luborsky, 1993).

Stages of change.

Another model for understanding adherence to treatment is Prochaska &
DiClemente's (1982) transtheoretical model of change. This model has shown success in
applications to smoking cessation, weight loss, and alcoholism; however, its usefulness
extends to understanding premature termination of psychiatric treatment. As previously
mentioned, non-adherence to recommended treatment is highly correlated with psychiatric
recidivism.
The stages of change model includes five stages: precontemplation, contemplation,
preparation, action and maintenance. In pre-contemplation the individual is not aware of the
problem or has no desire to change the behavior. In contemplation, however, the individual
is aware that a problem exists but has made no formal decision to change. Preparation
involves the decision to take action on a particular problem, as opposed to the action stage in
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which the person begins to change his or her behavior effectively. Preventing relapses or
consolidating previous changes is the aim of the maintenance stage.
Evaluating patients' readiness to change at the onset of treatment may help determine
how effective the treatment will be. The person’s particular stage of change will, in part,
influence his or her ability to follow through on treatment recommendations. Individuals in
the preparation, action, or maintenance stage may be more likely to remain compliant than
those in the pre-contemplation or contemplation stage because they have already
implemented the change process. In fact, Smith, Subich, and Kalodner (1995) found that
premature termination of therapy among college students is more likely for those in the precontemplative stage. This finding may have applications in explaining frequent treatment
failures among psychiatric inpatients. Knowledge of patients' readiness to change is an
important factor in evaluating appropriate treatments and predicting adherence.

The role of beliefs.

Horne (1999) stresses the importance of patient beliefs in treatment outcome. He
suggests that treatment outcome is the result of an interaction between patients’ beliefs about
the illness, beliefs about treatment and perceived outcome from treatment. Furthermore, he
states that patients’ beliefs about illness influence their decisions regarding the necessity of
treatment, and that negative beliefs about medication are linked with noncompliance. For
instance, many patients view medications as harmful and overused by doctors. Others may
have overly positive views of medication that can lead to inappropriate demands for
medication or to its inappropriate use. In an earlier study, Horne (1997) found that concerns
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about medication were related to non-adherence even when medication was believed to be
necessary and effective. Some of the medication-related concerns refer to their actual or
perceived potential for addiction or dependence, beliefs that medications are unnatural and
overused by physicians, and concerns about their long-term negative or harmful effects.
Horne points out that such medication-related beliefs might influence patients’ decisions
about other auxiliary treatments. He suggests using the necessity-concerns construct as a
way of understanding patient beliefs. This involves evaluating patients’ beliefs about the
necessity of treatment yet eliciting any concerns related to the treatment. Although this
construct seems to be useful in understanding patient beliefs, there appears to be no formal
way of assessing these beliefs with psychiatric patients.
Weinman and Petrie (1997) also discussed the importance of assessing patient' beliefs
about their illnesses. They believe that it is important to assess these beliefs or illness
perceptions early in treatment because of their relationship to adherence, emotional distress
and illness related disability. Similarly, others have found that distorted or irrational health
related beliefs can influence adherence to treatment or discounting of medical advice
(Christensen, Moran & Wiebe, 1999). Others have suggested a self-regulatory model in
understanding treatment adherence. This includes cognitive representations of the illness,
including beliefs about the etiology of the illness, its symptoms, personal consequences of
the illness, perceived duration, and the amenability of the illness to control or to cure
(Leventhal, Nernez & Steele, 1984; Leventhal, Diefenbach & Leventhal, 1992). These
underlying cognitive representations help patients make sense of their own experiences and
guide their coping responses. Similarly, Marlatt and Gordon (1985) have discussed the
importance of cognitive factors in the process of recovery from substance abuse or
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dependences, which includes self-efficacy (e.g., subjective sense of control or ability to
cope), outcome expectancies (e.g., anticipated effects) and attributions about lapses and
relapses.
Other cognitive and personality factors influencing health related behaviors are health
locus of control (Wiebe & Christensen, 1996), trait conscientiousness (Booth-Kewly &
Vickers, 1994) and unrealistic optimism (Weinstien, 1982, 1983, 1984). According to Locus
of control, a social learning theory construct (Rotter, 1966), peoples’ expectations of
desirable outcomes may be contingent, in varying degrees, upon their own behavior or as the
result of external factors. Because locus of control appears to be a generalized and stable
personality characteristic, it can be a useful concept in understanding health-related behavior.
A number of studies have looked at the association between locus of control and adherence
with mixed results, although some studies find that medical patients with higher internal
locus of control are more likely to adhere to treatment (Wiebe & Christensen, 1996).
Conscientiousness refers to the tendency to be goal and future oriented, responsible and
reliable. Conscientious individuals are able to delay immediate gratification and are
disciplined in the pursuit of long-term goals. Not surprisingly, conscientiousness has been
found to be a strong predictor of health-related behaviors (Booth-Kewly & Vickers, 1994).
Additionally, cognitive appraisals of susceptibility to health risks are believed to be
important in understanding adherence to treatment. Studies have shown that some people are
unrealistic about their vulnerability to health risks and demonstrate an optimistic bias
(Weinstien, 1982, 1983, 1984). This unrealistic optimism can lead to premature termination
of treatment, or can result in an expectation that professional treatment is not needed. The
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ability to identify and correct such distorted cognitive representations of illness and recovery
is an important component in increasing patient compliance with treatment.

Purpose of the Study

The purpose of this study is to develop the Zahn-Given Recovery Beliefs
Questionnaire (RBQ) originally developed by B. Zahn (personal communication, October
2001), and to show that it has adequate psychometric properties. The RBQ is being
developed to assess beliefs and attitudes toward recovery and aftercare in psychiatric
patients. Similar instruments have been developed within the addiction field (Myers, Martin,
Rohsenow, & Monti, 1996; Miller & Tonigan, 1996) as well as for use with medical patients
(Christensen, Moran, & Wiebe, 1999; Horne, 1999; Weinman, Petrie, Moss-Morris & Horne,
1996). Cochran and Gitlin (1988) developed a scale to assess specific beliefs related to
Lithium compliance in patients with bipolar disorder; however, to date, no scales have been
developed to assess the general recovery beliefs of psychiatric patients. The proposed scale
will be used to assess how well patients understand the process of recovery for their
psychiatric condition, as well as their need for ongoing aftercare.

Importance of study

There are a number of reasons why it is important to develop interventions to reduce
psychiatric recidivism. The costs of recidivism are many, including its impact upon
individuals, families, communities, and society; these costs also extend to its economic
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impact. On an individual level, patients who are routinely readmitted to hospitals may have
significantly diminished self-esteem or self-worth. They may also possess feelings of
inadequacy, inferiority, hopelessness and helplessness. Many recidivists may develop
dependence on others, including families and institutions, believing that they are incapable of
managing life on their own. Family relationships may become strained from the frustration
that many might feel towards patients who are seemingly incapable of leading productive
lives. As patients perceive that their support systems diminish, they may become more
desperate and more liable to be re-hospitalized in the future as their only safe haven. Once
hospitalized, discharge planning becomes complicated by the fact that some of the supports
that the patients once had are no longer available to them. The result may be that patients
whose families refuse to take them back are discharged with inadequate housing, and find it
necessary to live in a boarding home or a shelter. This change in housing and disruption of
family support makes it more likely for these patients to require re-hospitalization in the
future.
More broadly, the community and societal impact is that recidivism may help to
promote the stigma of mental illness, reinforcing the belief that people with mental illness are
incapable of leading functional lives. The economic impact can be seen by the decreased
reimbursement rates, the denial of covered services and shorter lengths of inpatient stay,
resulting in an overall reduction in the quality of care given to these patients. Furthermore,
many psychiatric patients are unemployed or disabled and may not have sufficient financial
resources available to them. In fact, mental illness ranks as the number one cause of
disability in the United States, Canada and Western Europe (WHO, 2001). Of those
receiving disability benefits, many have little to no disposable income to put back into the
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economy. The Department of Health and Human Services (1999) has estimated that the
economy’s loss of productivity from mental illness amounts to $63 billion annually. Given
the many costs of recidivism, it is important to develop interventions aimed at reducing nonadherence and recidivism among psychiatric patients. The present study aims to investigate
cognitive factors related to recidivism that may be amenable to psychological interventions.

Specific Hypotheses

1. The Zahn-Given Recovery Beliefs Questionnaire (RBQ) will demonstrate content
validity as established by a panel of independent experts.
2. The RBQ will demonstrate construct validity as evidenced by a factor structure that
includes pessimism or negative expectations about treatment, concerns about side effects,
perceived disadvantages of treatment, embarrassment, and unrealistic optimism.
3. Total score of the RBQ as well as its subscales will possess a coefficient alpha of at least
.70.
4. Recidivists will significantly differ from non-recidivists on total RBQ scores.
5. Total RBQ scores will be positively correlated with Beck Hopelessness Scale (BHS)
scores. In addition, high unrealistic optimism scores on the RBQ will show an inverse
relationship to BHS scores.
6. Total RBQ scores will be positively correlated with total Dysfunctional Attitude Scale
(DAS) score.
7. Total RBQ scores will be negatively correlated with treatment compliance scores.
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8. Total RBQ scores for patients who are non-compliant with treatment will be significantly
higher from those who seek treatment and drop out prematurely, regardless of the number
of previous psychiatric admissions.
9. The cognitive variables that correlate the highest with recidivism will be hopelessness
(total BHS score) and unrealistic optimism (RBQ subscale score).
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Method
Participants

Subjects were recruited from a group of psychiatric inpatients from Friends Hospital
in Philadelphia, PA. The primary unit patients were selected from was East 2, an acute
inpatient adult unit serving male and female patients ranging in age from 18-65.
Demographic data was obtained including age, gender, psychiatric diagnosis, level of
education, degree of compliance with outpatient care and number of hospitalizations in the
previous year. All subjects volunteered to participate in the study and were able to withdraw
at any time.
Participants eligible for the study were those with a primary diagnosis of major
depressive disorder, bipolar disorder, schizophrenia, schizoaffective disorder, obsessivecompulsive disorder, post-traumatic stress disorder, panic disorder, generalized anxiety
disorder, borderline personality disorder and other mood and psychotic disorders. Subjects
with a co-morbid diagnosis of substance abuse or dependence were also included. Patients
excluded from the study were those who had a primary diagnosis of delirium, dementia,
mental retardation or other cognitive disorders. These patients were not included in the study
because of their impaired cognitive functioning. The admission psychiatric evaluation was
used to determine eligibility using DSM-IV-TR criteria (APA, 2000). Patients who left the
hospital before completing treatment (e.g., elopement, discharged against medical advice,
etc.) were not included in the study.
Subject variables were used to determine recidivists and non-recidivists. Criteria for
recidivists included those patients who have had three or more inpatient admissions in the
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previous 12 months, or those readmitted to a psychiatric hospital within 90 days of their last
discharge. Hospital records were used to verify admission data. Additionally, dates of
admission to other psychiatric facilities were obtained from the patient as well as from the
patient’s insurance carrier (if applicable) to capture hospitalizations at other institutions.
Non-recidivists were those patients with fewer than three psychiatric admissions within the
prior year, or those with more than 90 days between two separate admissions.
Hospitalization information was verified whenever possible to establish the reliability of the
data.

Overview of Research Design

The present study is correlational by design and consists of two separate phases. The
first phase involved using a panel of independent experts to formally develop the RBQ. The
second phase involved administering the RBQ to patients to establish its psychometric
properties. Subjects were administered the RBQ upon admission to the hospital and one
week later, or on the day of their discharge, whichever came first. Subject responses to the
RBQ were correlated with several patient factors, including compliance with outpatient
treatment, adherence to prescribed psychiatric medication, number of hospital admissions in
the previous year, and total number of days hospitalized in the previous year. Additional
measures were correlated with RBQ scores, including the Beck Hopelessness Scale (Beck et
al., 1974) and the Dysfunctional Attitudes Scale (Weissman, 1979).

Development of the RBQ
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Item generation and selection.
Test items were derived from a review of relevant literature. Several sources were
used to generate scale items, including discussions with patients, psychologists, psychiatrists,
social workers and psychiatric nurses in inpatient settings who were experienced in working
with this patient population. Furthermore, the factors involved in non-adherence as proposed
by Meichenbaum & Turk (1987) were used as a basis for generating scale items. Content
areas were presented in an effort to reflect the “universe” of cognitive factors leading to
treatment non-adherence or to subsequent treatment failure. Some of the content areas under
investigation included uncertainty about treatment, past experience with symptoms, past
experience with health care providers, expectations about treatment, concerns about side
effects, perceived disadvantages of treatment, embarrassment, pessimism, impatience, and
unrealistic optimism. . Appendix A reflects the proposed scale items prior to expert review.

Scale construction & expert review.

Three independent experts were used to review the proposed content areas and scale
items. Each expert reviewer was a doctoral-level mental health professional, having a
minimum of five years experience with inpatient psychiatric patients. The expert review
process involved several steps. The first step was to review the proposed variables or content
areas (See Table 3). The task of the reviewers was to decide whether or not the proposed
variables reflected the “universe” of cognitive factors believed to be important in the process
of recovery. An additional category regarding the “therapeutic alliance” was proposed for
inclusion by one of the reviewers; however, the two other experts believed that this was

26

subsumed under other variables. Two variables, “paralysis of will and “hostility” were
eliminated during the review process. Of the major content areas selected for final inclusion
in the instrument, a criterion of 100% agreement between independent experts was achieved
(see Table 4).

Table 3
Proposed Variables Prior to Expert Review
Uncertainty about the efficacy of treatment
Prior experience with illness and changes in patient’s health
Expectations about symptoms, illness, health care providers, and treatment
Past experiences with health care providers
Concerns about possible side effects
Determination that costs outweigh benefits
Embarrassment about being in treatment
Pessimism or skepticism about the effectiveness of treatment
Impatience with the level of progress or the treatment process
Competing demands that are deemed more important
Paralysis of will
Viewing treatment as interfering with future plans, relationships, self-concept or daily life
Unrealistic Optimism
Hostility
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Once agreement was achieved on the content areas, the reviewers examined the
definitions of each content area to assure that each definition accurately reflected the
proposed cognitive domain. Reviewers indicated this by a “Yes” or “No” response.
Definitions were reviewed and modified based upon input from the review process. This
process was repeated until a criterion of 100% agreement on the definitions of the content
areas was achieved. (see Table 5).

Table 4
Selected Variables Following Expert Review
Uncertainty about the efficacy of treatment
Prior experience with illness and changes in patient’s health
Expectations about symptoms, illness, health care providers, and treatment
Past experiences with health care providers
Concerns about possible side effects
Determination that costs outweigh benefits
Embarrassment about being in treatment
Pessimism or skepticism about the effectiveness of treatment
Impatience with the level of progress or the treatment process
Competing demands that are deemed more important
Viewing treatment as interfering with future plans, relationships, self-concept or daily life
Unrealistic Optimism
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Table 5
Variables and Definitions Following Expert Review
Variable

1. Uncertainty about the efficacy of
treatment
2. Prior experience with illness and
changes in patient’s health
3. Expectations about symptoms,

Definition

Not being sure that treatment will do what I want it
to.
Beliefs about recovery that arise out of past
improvements and setbacks.
Beliefs related to the course of an illness, control

illness, health care providers, and

over related symptoms and generalized beliefs

treatment

about therapists, psychologists, psychiatrists and
psychiatric/psychological treatment.

4. Past experiences with health care
providers

Beliefs that arise out of positive and negative
experiences with therapists, psychologists, and
psychiatrists that influence the likelihood of
seeking psychiatric/psychological treatment and/or
staying with the current course of treatment.

5. Concerns about possible side
effects

Fears or worries about experiencing negative
outcomes from medication or psychotherapy (e.g.,
physical discomfort, emotional distress,
relationship difficulties, etc.)

6. Determination that costs outweigh
benefits

Deciding that there are more disadvantages to
psychiatric or psychological treatments than there
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are advantages (e.g., cost, stigma, time constraints,
shame, etc.)
7. Embarrassment about being in
treatment
8. Pessimism or skepticism about the
effectiveness of treatment
9. Impatience with the level of
progress or the treatment process

Resistance or reluctance to engage in treatment
based on fear of negative evaluation from others.
Thinking that treatment (medication or therapy) is
not very likely to help or won’t help at all.
Feeling frustrated with a lack of significant
progress within an expected time frame, which
influences a person’s willingness to stay with the
treatment.

10. Competing demands that are
deemed more important

Thinking that your time and energy is better spent
on things other than treatment (e.g., work,
childcare, household responsibilities, etc.)

11. Unrealistic optimism

Having overly simplistic and naïve beliefs about
how stay emotionally healthy, well and/or stable.

Once the content areas had been established, the proposed scale items were subjected
to expert review. The first step in this process was to have the proposed items examined for
grammar and clarity. Items were presented in a random sequence rather than under a
presumed category. Reviewers decided if an item was clear, understandable and
grammatically correct by indicating “Yes”, “No” or “Reword”. Items were retained,
discarded or reworded as needed. Items receiving 100% agreement were automatically kept.
Eleven items were judged to be acceptable by two out of three reviewers. These items were
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reworded and resubmitted for review and 100% agreement among reviewers was achieved
for the revised items. However, four items were discarded because only one of the three
reviewers found those items acceptable.
The next step in the review process was to have each of the reviewers independently
sort the items into the proposed content areas. Reviewers were provided with a list of the
proposed categories, including their definitions. The task of the reviewers was to read each
item carefully and to decide into which category to place the item. Items were printed on
individual cards so that they could be sorted into piles corresponding to the proper category.
Once completed, the items were reviewed to ascertain that they had placed them in the proper
category. Reviewers were instructed to include only those items that should be retained for
the final instrument. A “discard” category was included as an option during this sorting
process. The 20 items retained for the final instrument reflect 100% agreement in the sorting
of items. These items were then randomly sorted, thus making up the final instrument (See
Appendix B).

Scale Administration

Subjects were administered the Zahn-Given Recovery Beliefs Questionnaire (RBQ),
the Dysfunctional Attitude Scale- A (DAS-A) (Weissman, 1979) and the Beck Hopelessness
Scale (BHS) (Beck et al., 1974). The scales were administered in the above order within 24
to 48 hours of admission to the hospital. Informed consent was obtained for all participants
before collecting any data. Demographic data and hospitalization history was also collected
in collaboration with the hospital utilization review staff. Compliance with treatment scales
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were completed by both the subject (Appendix C) and a treating clinician (i.e., psychiatrist,
therapist, social worker or psychiatric nurse) (Appendix D). A total compliance with
treatment score was calculated for each scale based on these data.

Measures
Zahn-Given Recovery Beliefs Questionnaire (RBQ)

The Zahn-Given Recovery Beliefs Questionnaire (Zahn & Given, 2002) is a 20 item
self-report measure of beliefs related to recovery from psychiatric illness. The RBQ is
composed of short statements that reflect beliefs related to psychiatric treatment and
recovery. Responses are made on a 5 point Likert scale from 0 = not at all to 4 = totally.
Additionally, respondents had the option of selecting “does not apply” for each individual
item.

Beck Hopelessness Scale (BHS).

The Beck Hopelessness Scale (BHS) (Beck, et al., 1974) is being used to establish
construct validity. The BHS, a self-report measure, consists of 20 true-false items that assess
patients’ level of hopelessness about both short term and long term future events. It has been
shown to be both a reliable and valid measure of hopelessness having high internal
consistency (.87—.93) and a 6-week test—retest reliability of .66 ( Beck & Steer, 1988 ).
The BHS predicts suicidal intent and behavior much better than self-report measures of
depression alone (Beck & Steer, 1988). It is believed that high BHS scores will correlate

32

with items of the RBQ that assess hopelessness about recovery. Furthermore, low scores on
the BHS should show an inverse relationship to high unrealistic optimism scores on the
RBQ.

Dysfunctional Attitudes Scale (DAS).

The Dysfunctional Attitudes Scale, Form A (DAS-A) (Weisman, 1979) is being used
to establish construct validity. The DAS is a 40-item instrument that measures cognitive
distortions that underlie depression. Responses to items are made using a 7-point Likert
scale ranging from “totally agree” to “totally disagree”. Two versions of the DAS are
available (Forms A and B) with inter-test correlations between total score and parallel forms
ranging from .84 to .97. High scores on the DAS indicate the presence of a distorted thinking
style, whereas low scores indicate a more adaptive cognitive style. Six-week test-retest
reliability is .73 and DAS and BDI scores have a correlation coefficient of .41 (Oliver &
Baumart, 1985). It is believed that high scores on the DAS will correspond to items on the
RBQ that reflect a similar distorted thinking style.

Number of previous hospital admissions.

The number of previous hospitalizations was calculated upon the patient’s admission
to the hospital. This number represented hospitalizations within 12 months of the current
hospital admission. Data was collected from the patient and verified whenever possible by
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hospital records or by contacting the patient’s insurance carrier (if applicable) to capture
hospitalizations at other institutions.

Total days hospitalized.
The total number of days a patient was hospitalized was calculated for one calendar
year using the same process as above. This number was determined after the patient was
discharged from his or her current hospital admission. The day of discharge from the current
hospitalization determined the preceding 12-month period. For example, the number of days
hospitalized for a person discharged on 6/5/03 would be calculated starting from 6/5/02.
Again, an attempt was made to establish the reliability of the data using the method described
above.

Compliance with treatment.

A total treatment compliance score was calculated, using patient and clinician ratings
of statements regarding compliance with outpatient care and adherence with prescribed
psychiatric medication (See Appendix C & D). Compliance with outpatient care was based
on self and other-reports, using a 5 point Likert Scale to assess degree of adherence to
psychiatric appointments and medication. Subjects were asked to rate statements regarding
their compliance with outpatient care and degree of adherence to their psychiatric medication
using the following scale: 0 = does not apply, 1 = totally agree, 2 = agree somewhat, 3 =
neutral, 4 = disagree somewhat, 5 = totally disagree. (See Appendix C). Similarly, clinician
ratings (i.e., psychiatrist, therapist, social worker or psychiatric nurse) were also used to
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assess degree of adherence. (See Appendix D). These assessments were also aimed at
differentiating between patients who did not comply with recommended aftercare compared
with those who terminated treatment prematurely. Treatment non-compliance will be
indicated for patients who did not attend any of their previously recommended aftercare
appointments (e.g., outpatient therapy, psychiatric appointments, partial hospital, intensive
outpatient program, etc.) within the previous six months or since their last hospitalization (if
fewer than 6 months). Premature termination differs from non-compliance, which is defined
for patients who attended only a few sessions before dropping out altogether. This is an
important distinction because it is believed that different cognitive variables influence those
who decide to seek treatment and then drop out, as opposed to those who never seek
treatment when it is recommended. Similarly, non-compliance with medication and
medication misuse need to be differentiated. Non-compliance with medication will be
indicated for patients who failed to take any of their prescribed medications in the 6 months
prior to their current hospitalization or since their last hospitalization (if fewer than 6
months). This contrasts with misuse of medication, which is designated for patients who have
taken their medications in a way that is inconsistent with the way in which it is prescribed
(i.e., reducing or increasing the dose, skipping doses, taking it inconsistently, etc.).
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Results

In this section the demographic and diagnostic characteristics of the sample will be
reviewed. Compliance with treatment data is also presented here, followed by a factor
analysis of the RBQ. Correlational analyses were conducted and the findings are reviewed.
Furthermore, a reliability analysis of the RBQ is presented.

Descriptive Statistics

A total of 100 subjects were used for this study. Descriptive statistics for the sample
are presented below. Table 6 presents demographic data regarding gender, employment
status, marital status, educational level, housing and ethnicity; and table 7 shows the
diagnostic characteristics of the sample.

Age. Ages ranged from 18 to 63 years old. The mean age for the sample was 37.86
years with a standard deviation of 10.98. No significant difference in age was found between
recidivists and non-recidivists (t = -1.35, df = 98, p < .18).

Gender. Males composed 73% (n = 73) of the total sample compared with 23% (n =
23) for females. Recidivists were comprised of 25 males (81%) and 6 females (19%),
compared to 48 males (70%) and 21 females (30%) for non-recidivists.
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Marital status. Marital status distribution consisted of 52 % who were single (n = 52),
14% who were married (n = 14), 14% who were separated (n =14), 16% who were divorced
(n =16), and 4% who were widowed (n = 4).

Employment status. The employment status of the sample reflects that 24% were
employed full-time (n = 24), 8% were in part-time employment (n = 8), 31 % were
unemployed (n = 31), and 37% were disabled (n = 37).

Educational level. The level of education subjects achieved reflects 22% of the
sample who never finished high school (n = 22), 31% were high school graduates (n = 31),
9% had a GED (n = 9), 18% had some college experience (n = 18), 12 % were college
graduates (n = 12), and 8% had a graduate or advanced degree (n = 8).

Housing condition. The housing condition of the sample reflects a distribution of
75% who lived independent housing (n = 75), 8% were in supported housing (n = 8), 6%
were homeless (n = 6), 9% lived in a recovery house (n = 9) and 1% lived in a shelter (n = 1).

Ethnicity. The ethnic distribution of subjects revealed 15% of the sample was African
American (n = 15), 75% Caucasian (n = 75), 8% Hispanic (n = 8), and 2% were of other
ethnic origin (n = 2).
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Table 6
Demographic Data
Age

Educational level

Range

18-63

Never finished high school

22 %

Mean

37.86

High school graduate

31 %

GED

9%

Gender
Male

73 %

Some college

18 %

Female

27 %

College graduate

12 %

Graduate/ advanced degree

8%

Employment status

Housing condition

Full time

24 %

Part time

8%

Independent housing

75 %

Unemployed

31 %

Supported housing

8%

Disabled

37 %

Homeless

6%

Shelter

1%

Recovery house

9%

Marital status
Single

52 %

Married

14 %

Separated

14 %

African American

15 %

Divorced

16 %

Caucasian

75 %

Widowed

4%

Hispanic

8%

Other

2%

Ethnicity
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Recidivists. Recidivists accounted for 31 % of the sample (n = 31) compared with 69
% of non-recidivists (n = 69). Recidivists were more frequently male (81%, n = 25), single
(42%, n = 13), and Caucasian (81%, n = 25). Also, they were more frequently disabled
(48%, n = 15), high school graduates (35%, n = 11), and lived in independent housing (55%,
n = 17).

Psychiatric Diagnosis. The diagnostic characteristics of the sample are presented in
Table 7 and include mood disorders 75% (n = 75), psychotic disorders 18% (n = 18), anxiety
disorders 3% (n = 3), and other psychiatric disorders 4% (n = 4). A secondary diagnosis was
coded for 46% of the total sample (n = 46), including substance abuse/dependence 34% (n =
34), personality disorders 5% (n = 5), mood disorders 2 % (n = 2), anxiety disorders 2% (n =
2) and other psychiatric disorders 3% (n = 3). Mood disorders were most common among
recidivists (71%, n = 22) followed by psychotic disorders (26%, n = 8). Non-recidivists were
more frequently being treated for mood disorders (77%, n = 53) followed by psychotic
disorders (14%, n = 10). Co-morbid substance abuse/dependence accounted for 45% of
recidivists (n = 14) and personality disorders were present in 10% of this group (n = 3).
Recidivists did not differ from non-recidivists on primary diagnosis (Chi square = 3.03, df =
3, p < .386) or secondary diagnosis (Chi square = 2.27, df = 4, p. < .686).
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Table 7
Diagnostic Characteristics of the Sample
Primary Diagnosis

Frequency

%

Major Depression

29

29 %

Bipolar disorder

22

22 %

Depressive Disorder NOS

15

15 %

Schizophrenia

10

10 %

Schizoaffective Disorder

5

5%

Mood disorder NOS

4

4%

Psychotic Disorder NOS

2

2%

Obsessive Compulsive Disorder

2

2%

Panic Disorder

1

1%

Adjustment Disorder NOS

1

1%

Delusional Disorder

1

1%

Impulse Control Disorder NOS

1

1%

Substance Induced Psychotic Disorder

1

1%

Frequency

%

Substance abuse/dependence

34

34 %

Personality disorders

5

5%

Major Depression

1

1%

Obsessive Compulsive Disorder

1

1%

Depressive Disorder NOS

1

1%

Adjustment Disorder with Depressed Mood

1

1%

Secondary Diagnosis
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Post Traumatic Stress Disorder

1

1%

Number of hospitalizations. The total number of hospitalizations subjects had in the
previous year ranged from 1 to 7 with a mean of 1.94 and a standard deviation of 1.41.
Recidivists were hospitalized an average of 3.55 times (S.D. = 1.5) compared with 1.20 for
non-recidivists (S.D. = .41)

Days hospitalized. Total days hospitalized for the previous 12 months ranged from 2
to 121 with a mean of 15.93 and a standard deviation of 19.33. The median was 9.0 days.
Recidivists were hospitalized an average of 36.48 days (S.D. = 27.23) compared with 8.66
for non-recidivists (S.D. = 6.89)

Table 8
Comparison of Mean Number of Hospitalizations and Total Days Hospitalized
Recidivist

Number of Hospitalizations

SD
Total Days Hospitalized

SD

Yes

No

Total

3.55

1.20

1.94

(N=31)

(N=68)

(N=99)

1.5

.41

1.41

36.48

8.66

15.93

(N=23)

(N=65)

(N=88)

27.23

6.89

19.33

41

Compliance with treatment. Table 9 presents data regarding subjects’ compliance
with treatment. 68% of subjects (n = 68) stated that they had taken psychiatric medication in
the previous six months or since their last discharge, compared with 32% (n = 32) who did
not. 50% of the people (n = 16) not taking medication answered “yes” when asked, “Has
anyone ever recommended that you take psychiatric medication?” 44% (n = 44) said that
they had not attended outpatient treatment (e.g., therapy, intensive outpatient treatment,
partial hospitalization, etc.) in the previous 6 months or since their last hospitalization even
when it had been recommended to 71% of this group (n = 31). 23% said that they did not
complete their treatment (n = 13) compared with 13% who did (n = 7). 64% (n = 34) said
that their treatment was still in progress at the time of their hospitalization.

Table 9
Compliance with Treatment

Frequency

%

Taking medication prior to hospitalization

68

68%

Not taking medication prior to hospitalization

32

32%

16

50%

44

44%

31

71%

Did not complete treatment

13

23%

Completed treatment

7

13%

Treatment still in progress

34

64%

Medication previously recommended
Not in outpatient treatment prior to hospitalization
Treatment previously recommended
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Factor Analysis of the RBQ
A principal components, varimax rotated factor analysis using Kaiser’s Criterion was
conducted. The 20 items of the RBQ were analyzed and 6 factors were extracted, accounting
for 70.06 % of the total variance. A total scale Coefficient Alpha of .82 demonstrates
acceptable levels of internal consistency. Using a factor loading criteria of .55 or greater, 4
factors were retained, accounting for 56.14 % of the total variance. These factors are 1)
Embarrassment/ Stigma ( = .85), 2) Unrealistic Optimism ( = .61), 3) Pessimism/
Hopelessness ( = .79), and 4) Concerns About Side Effects ( = .76). Table 10 presents the
distribution of the items to corresponding factors and factor loadings for each item. Results
indicate that items that loaded on these factors closely reflect 4 of the hypothesized subscales
of the RBQ.
The first factor, Embarrassment/ Stigma ( = .85), consists of five items. This factor
accounts for the largest single variance of all factors on the scale. This factor appears to
measure subjective feelings of shame, embarrassment, and fear of negative evaluation by
others related to the need for psychiatric treatment. High scores on this factor reflect higher
levels of embarrassment, shame, and fear on negative evaluation.
The second factor, Unrealistic Optimism ( = .61), consists of four items. This factor
appears to measure overly simplistic and naïve beliefs about how to stay emotionally healthy,
well and/or stable. This factor would benefit from further development given its lower alpha
score. High scores on this factor reflect more simplistic and naïve beliefs related to recovery
from mental illness.
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The third factor, Pessimism/ Hopelessness ( = .79), consists of three items. The
items on this factor appear to measure negative expectations regarding the efficacy of
psychiatric treatment; that is, the extent to which subjects believe that treatment is not likely
to help them. High scores on this factor reflect higher levels of hopelessness and pessimism
related to treatment.
The fourth factor, Concerns About Side Effects ( = .76), consists of two items.
Items on this factor reflect worries related to the possibility of negative effects or side effects
from taking psychiatric medication. High scores on this factor reflect higher levels of worry
related to the side effects of taking prescribed psychiatric medication.
A Factor Analysis of Variance was also conducted for the RBQ. Table 11 presents
variance data using Rotated Sums Squared Loadings of the individual factors of the RBQ.
Percentage of variance and cumulative variance are presented for each factor. Factor 1
accounts for the largest percentage of variance at 19.63 % of the total variance (56.14 %).

Table 10
Factor Loadings of the of the RBQ
Factor 1: Embarrassment/
Stigma ( = .85)

Item
15. I am embarrassed about being in treatment, even

Item
Loading
.85

though I know I need it.
16. People will think I’m crazy if I tell them I am under
psychiatric care.

.81
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17. I feel ashamed when I talk about my problems.

.72

18. I worry about people in my life knowing that I am in

.77

psychiatric treatment.
20. I’m too busy to follow up with aftercare. I’ve got a

.56

lot of other priorities that come first like family,
work and childcare.
Factor 2: Unrealistic
Optimism ( = .61)

Item
6. I might need to take psychiatric medication even

Item
Loading
.59

when I am feeling better. (reversed item)
11. My discharge from this program means that I am

.76

fully recovered from my problems.
12. I feel better now, so I must be better. I don’t need to

.82

do anything else like going to appointments, taking
medication, or doing self-help homework.
13. All I have to do is stay away from the wrong people

.68

and I’ll be OK.
Factor 3: Pessimism/
Hopelessness ( = .79)

Item

Item
Loading

2. Having a mental illness means I’ll never get better.

.75

3. I have little faith in getting better, no matter what kind

.82

of treatment I receive.
4. Nothing can ever help me.

.82
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Factor 4: Concerns About
Side Effects ( = .76)

Item

Item
Loading

7. Taking medication will probably make me feel like a

.65

zombie.
8. I worry about becoming too dependent on my
medication.

Table 11
Explanation of Variance by Factors using Rotated Sums of Squared Loadings
Factor

% of Variance

Cumulative %

1

19.64

19.64

2

15.27

34.91

3

12.76

47.67

4

8.47

56.14

Correlation of the RBQ Factor Scores

Table 12 presents the intercorrelation of the RBQ factors. Pearson Product Moment
Coefficients were computed and are presented. The most highly correlated factors were
Factor 4, Concerns About Side Effects, with Factor 1, Embarrassment/ Stigma (r = .478, p <
.01). The second highest correlated factors were Factor 1, Embarrassment/ Stigma with

.69
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Factor 3, Pessimism/ Hopelessness (r = .396, p < .01). Factor 3, Pessimism/ Hopelessness
was also correlated with Factor 4, Concerns About Side Effects (r = .294, p < .05).

Table 12
Pearson Inter-correlation Matrix of RBQ Factors

Factor 1

Factor 2

Factor 3

Factor 4

Factor 1

-

.172

.396*

.478*

Factor 2

-

-

.153

-.020

Factor 3

-

-

-

.294*

Factor 4

-

-

-

-

* Correlation significant at the 0.01 level (2-tailed)

Coefficient Alpha Reliability

Two measures of reliability were calculated to test the internal consistency of the
RBQ, a total scale estimate of internal reliability and subscale reliability estimates.
Chronbach’s coefficient alpha reliability analysis was conducted. Table 13 presents alpha
scores for the total scale and for each factor.
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Table 13
Coefficient Alpha Reliability for the RBQ
Factor

Description

Coefficient Alpha

1

Embarrassment/ Stigma

.85

2

Unrealistic Optimism

.61

3

Pessimism/ Hopelessness

.79

4

Concerns About Side Effects

.76

Total Scale

.82

Test-Retest Reliability

Fifty-two subjects (52 %) were administered the RBQ one week later or on their
discharge from the hospital, whichever came first. The mean length of time for the second
administration of the RBQ was 5.7 days (SD = 2.27). Test-retest reliability for the RBQ is
.62 (p < .01) indicating a possible influence of intervening treatment on distorted styles of
thinking between the first and second administration of the scale.

Correlation of the RBQ with the DAS & BHS

To test whether or not the RBQ correlated with other measures of distorted thinking,
a correlational analysis using the Pearson Product Moment Coefficient of Correlation was
conducted. Total RBQ scores were correlated with total Beck Hopelessness Scale (BHS)
scores and Dysfunctional Attitudes Scales (DAS) scores. Additionally, total BHS scores
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were correlated with the Pessimism/ Hopelessness factor of the RBQ. Results are presented
in Table 14.
The RBQ demonstrates construct validity as evidenced by positive correlations with
the Beck Hopelessness Scale (r = .29, p < .05). This means that approximately 8 % of the
variability on the BHS is attributable to differences on the RBQ; the other 92 % is
attributable to other factors. A positive correlation was also obtained for the RBQ and the
Dysfunctional Attitudes Scale (r = .46, p < .01), which also measure distorted styles of
thinking. This means that approximately 21 % of the variability on the DAS is attributable to
differences on the RBQ, and the other 79 % is due to other factors. Total BHS scores also
correlate with the Pessimism/ Hopelessness (PES/HOP) factor of the RBQ (r = .41, p < .01).
This factor was also highly correlated with total RBQ scores (r = .65, p < .01). Additionally,
the unrealistic optimism factor (UNREAL) was negatively correlated with total BHS scores
(r = -.187, p < .05).
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Table 14
Correlation of the RBQ with other Measures
UNREAL

BHS

DAS

PES/HOP

RBQ

-

.289*

.463*

.647*

BHS

-.187**

-

.478*

.414*

DAS

-

-

-

.377*

PES/HOP

-

-

-

-

*Correlation significant at the 0.01 level (one-tailed)
** Correlation significant at the 0.05 level (one-tailed)

Comparison of Recidivists and Non-Recidivists

A Chi Square analysis revealed no significant difference between groups on
diagnosis, gender, marital status, ethnicity, employment status, housing condition and
educational level; suggesting homogeneity of the two groups. Total RBQ scores for
recidivists (mean = 15.74; SD = 9.9) did not differ significantly from non-recidivists (mean =
15.88; SD = 8.20). Although no significant difference was found between groups on total
RBQ scores, non-recidivists scored significantly higher than recidivists on the Concerns
About Side Effects factor of the RBQ (t = 2.07, df = 91, p < .05). The mean score on this
factor for recidivists was .96 (SD = 1.09) compared with a mean score of 1.53 (SD = 1.26)
for non-recidivists. Total BHS scores were significantly correlated with recidivism (r = .263,
p < 0.01); however, no significant correlation was found for the Unrealistic Optimism factor.
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Correlation of the RBQ with Compliance with Treatment Ratings

Subjects’ self-reported compliance with treatment scores did not significantly
correlate with total RBQ scores (r = -.049, p < .763). Furthermore, total RBQ scores did not
significantly correlate with clinician rated treatment compliance scores (r = .194, p < .258).
However, taking more medication than prescribed, as reported by treating clinicians, is
positively correlated with total RBQ scores (r = .38, p < .05).
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Discussion

The aim of this study was to design a self-report inventory that could measure the
presence of specific types of distorted beliefs related to the process of recovery from
psychiatric illness. The results of this study indicate that this has been accomplished. This
chapter, in addition to summarizing the results of the study, and discussing the relevancy of
the findings to the existing literature, will also cite the limitations of the current investigation.
There is also a discussion of recommendations for future research.

Discussion of Research Findings
In this study the Zahn-Given Recovery Beliefs Questionnaire was developed and its
psychometric properties were examined. A preliminary validation of the RBQ was
conducted using a sample of 100 psychiatric inpatients. Positive psychometric properties
were obtained, including (a) acceptable levels of internal consistency as evidenced by
coefficient alpha reliability scores; (b) acceptable levels of content validity as evidenced by
100 % agreement in the retention and sorting of scale items through expert review; and (c)
acceptable levels of construct validity as evidenced by a factor structure that includes four of
the hypothesized subscales (Embarrassment/ Stigma, Unrealistic Optimism, Pessimism/
Hopelessness, and Concerns About Side Effects), as well as positive correlations with the
BHS and DAS. In addition, a positive correlation between total BHS score and the
Pessimism/ Hopelessness factor of the RBQ was noted; a negative correlation between the
Unrealistic Optimism factor and the BHS was also obtained.
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Demographic Characteristics

A preliminary validation of the RBQ was conducted using a sample of hospitalized
psychiatric patients. A criterion was established to distinguish a subset of patients who were
identified as recidivists. Results of demographic data analysis indicated that the two groups
(e.g., recidivists and non-recidivists) were equally representative, with no significant
differences found in diagnosis, gender, marital status, ethnicity, employment status, housing
condition and educational level.
One purpose of this study was to identify whether or not recidivists endorsed more
distorted recovery-related beliefs compared with non-recidivists as evidenced by total RBQ
scores. It was hypothesized that recidivists would have a tendency to view recovery from
psychiatric illness in more distorted ways, as evidenced by non-adherence to outpatient
treatment and more frequent re-hospitalization. Results of the study indicated no significant
difference on total RBQ scores between groups; therefore, this hypothesis was not supported.
Recidivists obtained a total RBQ mean score of 15.74 (S.D. = 9.9) and non-recidivists
obtained a mean score of 15.88 (S.D. = 8.20). One possible explanation for this nonsignificant difference relates to the sample size and distribution of recidivists and nonrecidivists. A sample size of 100 was used to obtain a ratio of 5:1 for number of subjects to
number of scale items. Although this ratio was achieved, many validation studies of new
psychometric instruments use much larger sample sizes. Additionally, less than a third of the
total sample (31%, n = 31) was composed of recidivists. Using a larger sample size with a
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more equal distribution of recidivists and non-recidivists may have revealed a statistically
significant difference on total RBQ scores.
The only demographic variable that was significantly correlated with total RBQ
scores was related to use of prescription medication. Subjects who were reported taking
more medication than was prescribed, as evidenced by responses from treating clinicians,
obtained a significant correlation with total RBQ scores (r = .38, p < .05). This suggests that
patients who are liable to overuse their prescription medication possess more distorted views
about the process of recovery from psychiatric illness than those who do not. One possible
explanation for this may be a coping skills deficit, which causes individuals to have poorly
developed responses to situational stress or affective disturbance. Such individuals may
possess an external locus of control and underestimate their ability to affect positive change.
As such these patients may have a tendency to “self-medicate” during times of increased
stress.
Compliance with treatment data reveals that 68% (n = 68) of subjects reported taking
medication within the previous six months or since their last hospitalization (if fewer than six
months). Of the 32% (n = 32) not taking medication, half of this group (50%, n =16)
reported not taking medication even when it was recommended in the past. Furthermore,
44% (n = 44) of subjects were not attending any type of outpatient treatment at the time of
their hospitalization even when it had been recommended to 71% (n = 31) of this group.
Possible explanations for this include lack of resources (e.g., not having health insurance),
concerns about side effects, embarrassment, stigmatization, or other distorted beliefs (e.g., “I
should be able to handle my problems on my own”, or “Taking medication is a sign of
weakness”). There was not enough data to determine whether or not total RBQ scores for
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patients who were non-compliant with recommended treatment were significantly different
from those who sought treatment and dropped out prematurely.

Content Validity

The RBQ appears to demonstrate acceptable content validity as established by a panel
of experts and by factor analysis. The RBQ items were developed using clinical experience
and relevant literature. The items were designed as self-statements that reflected distorted
views related to recovery from psychiatric illness. Once a final item pool had been created,
three independent experts assisted in the development of the scale items. All of the items and
definitions were subject to a comprehensive review that included (a) cognitive factor
definition for construct accuracy (b) item content for grammar and clarity and (c)
independent sorting of items into related cognitive factors. Of the 62 originally pooled items
only 20 items were retained, which reflect 100% agreement on the selection and sorting of
scale items into related variables.

Construct Validity

A panel of three independent experts was used to establish the construct validity of
the RBQ. Experts were asked to decide whether or not the 14 proposed variables reflected
the “universe” of cognitive factors believed to be important in the process of recovery from
psychiatric illness. One reviewer suggested an additional category regarding the “therapeutic
alliance”. Although this is believed to be an important factor related to treatment adherence,
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the two other experts believed that the alliance was subsumed under other factors. Two
factors, “paralysis of will” and “hostility”, were eliminated during the review process due to
lack of consensus among expert reviewers. A criterion of 100% agreement between
independent experts was achieved for the 12 factors selected for final inclusion in the
instrument. Although there may be many other factors related to the nature of the research
question, there was an attempt made on the part of the researcher to limit the scope of the
instrument. Failure to do so would have led to the development of a rather lengthy and
impractical assessment tool.
To establish the construct validity of the RBQ, a correlational analysis was conducted
using the BHS and the DAS. These two measures were used because they both reflect
distorted and dysfunctional ways of thinking. The BHS was used primarily to determine
whether or not the construct of pessimism and hopelessness as evident in the
Pessimism/Hopelessness (PES/HOP) factor of the RBQ correlated positively with an
established measure of hopelessness. A positive correlation was obtained (r = .414, p < .01)
indicating that the PES/HOP factor reflects the construct that it was intended to measure. As
predicted, the Unrealistic Optimism (UNREAL) factor of the RBQ correlated negatively with
total BHS scores (r = -.187, p < .05). Because the UNREAL factor reflects overly optimistic,
simplistic and naïve recovery-related beliefs, it stands to reason that subjects who score
higher on this factor would also show lower levels of hopelessness.
Total scores obtained on the RBQ were also correlated with total DAS scores (r =
.463, p < .01). Additionally, BHS scores were correlated with total RBQ scores (r = .289, p <
.01). This suggests that subjects with distorted recovery-related beliefs as measured by the
RBQ tend to possess more global dysfunctional attitudes and levels of hopelessness.
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Factor Analysis of the RBQ

A principal component, varimax rotated factor analysis was conducted using Kaiser’s
Criterion. Results obtained from the factor analysis yielded significant results for the internal
structure of the scale. A total of six factors with eignvalues greater than one were extracted.
Using a factor loading criterion of .55 or greater, four factors were retained. Fourteen of the
20 items of the RBQ loaded on these factors. Of the total scale variance, 56.14% was
accounted for by four factors: Embarrassment/ Stigma, Unrealistic Optimism, Pessimism/
Hopelessness, and Concerns About Side Effects. These factors reflect four of the originally
hypothesized subscales of the RBQ. The following is a description of each factor.
Factor 1, Embarrassment/ Stigma included five items. This factor, accounting for the
largest single variance of all the factors in the scale (See Table 11), appears to tap into fear of
negative evaluation from others. High scores on this factor, as it relates to the need for
psychiatric treatment, reflect higher levels of shame, embarrassment and fear of being judged
by others. Those who score high on factor 1 believe that needing or seeking professional help
is something to be embarrassed and ashamed about. Also, they may worry that others will
think of them as “crazy” or defective if they reveal their need for treatment. The underlying
distorted belief appears to be, “I should be able to handle my problems on my own”. Factor
1 also correlated with Pessimism/ Hopelessness (r = .396, p < .01) and Concerns About Side
Effects (r = .478, p < .01). This suggests that individuals who experience higher levels of
shame and embarrassment also possess higher levels of hopelessness and more concerns
related to treatment.
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Factor 2, Unrealistic Optimism consists of four items. High scores on this factor
reflect an overly optimistic and unrealistic view of recovery. Subjects endorsing items on
this factor tend to view the recovery from psychiatric illness in a simplistic or naïve fashion.
They may fail to anticipate any difficulties or to develop appropriate relapse prevention plans
if such difficulties should arise. There may be a tendency for such individuals to seek
treatment only when there is a crisis. In an exploratory analysis it was noted that Factor 2
correlates negatively with self-reported compliance with treatment scores (r = -.348, p < .05).
This suggests that individuals with higher levels of unrealistic optimism tend to be less
compliant with recommended treatment. Also, there is anecdotal evidence that many patients
decompensate and require re-hospitalization because of these types of beliefs. For example,
one patient recently said “I was feeling better so I stopped taking my medication…I thought I
was better”. Indeed, this individual probably was doing better, not in spite of the medication,
but because of the medication. Stopping her medication when she was feeling better reflects
the type of thinking that factor 2 attempts to measure. Factor 2 would benefit from further
development, given its lower alpha level.
Factor 3, Pessimism/ Hopelessness, consists of three items. This factor appears to
measure overly distorted and negative views about recovery. Subjects who score high on this
factor have little faith in getting better. They perceive treatment in a negative light and feel
that nothing can help them overcome their current distress. High scores on this factor reflect
high levels of pessimism and hopelessness related to treatment. This factor appears to be
state-dependent, as is the BHS, and such beliefs might shift as patients experience subjective
relief during the course of their treatment.
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Factor 4, Concerns About Side Effects, consists of two items. High scores on this
factor reflect worries related to side effects from psychiatric medication. The concerns
reflected in these items involve impairment in functioning (e.g., feeling like a “zombie”) and
dependency (i.e., not being able to cope without the medication). It is conceivable that
individuals who score higher on this factor are less compliant with recommended medication.
In conclusion, factor analyses of the RBQ yielded four separate, underlying factors or
subscales closely matching the originally hypothesized factors.

Reliability of the RBQ

Two measures were used to test the internal consistency of the RBQ. This included a
total scale estimate of internal reliability as well as subscale estimates of internal reliability.
The total RBQ scale had a Cronbach’s alpha of .82. Coefficient alpha levels for subscales
are as follows: Embarrassment/ Stigma (.85), Unrealistic Optimism (.61), Pessimism/
Hopelessness (.79) and Concerns About Side Effects (.76). These results suggest that the
RBQ demonstrates acceptable levels of internal consistency among items and overall scale
content. Furthermore it suggests that the RBQ is a valid measure of four factors that are
derived from relevant research in understanding treatment non-adherence. Factor 2,
Unrealistic Optimism, would benefit from further development, given its lower alpha level.
Future investigations should include additional scale items to boost the reliability of this
factor.
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The test-retest reliability of the RBQ was also analyzed. The total test-retest
reliability for the RBQ was .62 (p < .01). An attempt was made to administer the RBQ one
week after completing the first administration of the scale; however, this was not always
possible due to some subjects having a length of stay less than a week. A total of 52 (52%)
subjects completed the re-test of the RBQ. Subjects who left the hospital prior to the oneweek interval were administered the scale on their day of their discharges. The mean number
of days between the first and second administration was 5.7 days (SD = 2.27).
To understand the test-retest reliability of the RBQ, it is important to consider the
influence of intervening treatment between administrations. Subjects who came into the
hospital received intensive treatment, including medication, group therapy, individual
therapy and activity based therapies. Many of the treatments may have directly impacted on
the belief system of the individual, particularly as he or she began to experience symptom
relief. For example, as levels of depression and hopelessness decreased with treatment, an
associated decrease would also be expected on the Pessimism/ Hopelessness factor on the
RBQ. Additionally, subjects who initially scored high on the Concerns About Side Effects
factor might have had fewer concerns related to their medication at re-test because they had
an opportunity to tolerate the medication for the preceding week. Again, a decrease in
medication-related concerns would be expected, assuming the subjects did not experience
any adverse reactions to their medication. Furthermore, embarrassment and stigmatization is
typically reduced in an inpatient setting by having open discussions around these issues and
by direct contact with others who have experienced similar symptoms or problems.
Physicians, therapists and nursing staff may have influenced beliefs associated with the
Unrealistic Optimism factor through direct discussion with subjects and through the
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educational efforts of the treatment team. Family members or significant others may have
been involved in the treatment process to help the patient develop an sense of increased
support while having an opportunity to discuss relapse prevention once discharged from the
hospital.
For these reasons it is understandable that the test-retest of the RBQ is lower than one
would hope for in an instrument development and validation study. However, reductions in
total RBQ scores from the first administration (mean = 15.78, SD = 9.36) to the second
administration (mean = 12.77, SD = 8.19) may be a reflection of a treatment program that
effectively impacts on distorted recovery-related beliefs. Also, lower test-retest reliability
might be a reflection of state-related thinking rather than a more global and pervasive
thinking style. The test-retest reliability of the RBQ is comparable to the re-test reliability of
the Beck Hopelessness Scale (.66) (Beck & Steer, 1988), which is another state-dependent
self-report instrument.

Implications for Treatment

The RBQ is the first measure of its kind aimed specifically at assessing recoveryrelated beliefs in psychiatric patients. The RBQ offers a formal way to assess the necessityconcerns construct as postulated by Horne (1999) with an inpatient psychiatric population.
The RBQ allows clinicians working with these patients the use of a formal assessment tool to
identify potential risk factors related to treatment non-adherence and potential relapse. One
aim of the RBQ is to assess the patient’s attitudes or beliefs related to recovery at the onset of
treatment. Responses on the RBQ can be used by the treatment team to develop a focused
and individualized treatment plan based on the patient’s responses. In other words, the RBQ
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can be used a first step in identifying distorted styles of thinking that may place the patient at
risk of subsequent treatment failure and/or relapse. If such distorted thoughts are identified
early in the course of treatment, they can then become a main focus of the patient’s
treatment. Individual therapy can help patients examine these beliefs and develop rational
responses. Furthermore, group programming can be used as a vehicle for exploring and
modifying those factors measured by the RBQ. By helping to modify or correct distorted
recovery-related beliefs, it is hoped that patients who are discharged from the hospital will be
more likely to comply with recommended aftercare, thus reducing the probability of relapse
and re-hospitalization.

Limitations of the Study

Although the current study aims to produce a relevant and clinically useful
assessment tool, there are several limitations in its design. The first relates to the sample
size. Although a ratio of participants to number of items of 5:1 was used, many self-report
instruments are developed using a much larger sample size. Furthermore, the number of
recidivists (n = 31) in this study limits the ability to draw comparisons between groups, and
may account for the lack of statistical significance on total RBQ scores.
Another limitation relates to how well the results can be generalized. Because an
inpatient sample from one facility is being used, the results may not have captured all of the
possible cognitive factors associated with treatment adherence and recidivism. It is possible
that a larger sample of psychiatric patients from different areas may have revealed different
beliefs about psychiatric illness and its treatment. Additionally, the proposed scale may not
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fully capture all of the possible cognitive factors associated with treatment non-adherence
and recidivism. To do so would require a rather extensive and perhaps impractical
assessment tool. Thus, there has been some effort on the part of the researcher to limit what
is included in the scale, based on relevant research and clinical judgment.
In addition to these limitations, the study does not include an outpatient sample
primarily because of the nature of the research question. However, it may be useful to
expand the current study to explore the recovery beliefs of an outpatient treatment group
compared with those beliefs of psychiatric inpatients.

Recommendations for Future Research

Recommendations for future research include adding items to weaker factors to
strengthen the content validity of the measure. This is especially true for the Unrealistic
Optimism factor, given its lower alpha level. A reassessment of the psychometric properties
of the RBQ, using a larger sample size that includes more recidivists, is needed to draw
comparisons between groups and to identify areas of intervention. Also it would be
interesting to test the factor structure of the RBQ further with both inpatient and outpatient
populations. Doing so would enable researchers and clinicians to identify and to intervene
with patients at risk of treatment failure and a pattern of relapse. Finally, it is hoped that the
RBQ can be used as a predictive measure of recidivism.

Conclusion
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Despite its limitations the Zahn-Given Recovery Beliefs Questionnaire provides a
valid and reliable measure of distorted beliefs surrounding recovery from psychiatric illness.
The RBQ possesses a factor structure that includes Embarrassment/ Stigma, Unrealistic
Optimism, Hopelessness/ Pessimism and Concerns About Side Effects. A total scale alpha
reliability of .82 indicates stability of the instrument. The RBQ demonstrates construct
validity as evidenced by positive correlations with the BHS and DAS, which also measure
distorted styles of thinking. Furthermore, the Pessimism/Hopelessness factor of the RBQ
correlates positively with the BHS. Future studies are needed to further develop the
psychometric properties of the instrument to make it useful tool in clinical practice.
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Appendices
Appendix A: Proposed Scale Items Prior to Expert Review
Reasons Why Patients May Decide Not to Adhere to Treatment
(Adapted from Meichenbaum & Turk, 1987)
Uncertainty about the efficacy of treatment
I am not sure that going to therapy or taking medication will do me any good.
It’s not likely that treatment will help me with my problems.
I don’t think that talking to a therapist will help.

Prior experience with illness and changes in patient’s health
I can usually get better on my own.
I think this problem will go away by itself.
Things will only get worse for me no matter what I do.
I have not found treatment helpful in the past.
Talking about my problems only makes me feel worse.

Expectations about symptoms, illness, health care providers, and treatment
I will always experience emotional problems because I have a chemical imbalance.
Having a mental illness means I’ll never get better.
Most therapists and doctors don’t know how to help me.
I might need to take psychiatric medication after I leave treatment here, even though I am
feeling better now.
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Once I start feeling better, I might decide to stop taking my medication or going to my
aftercare program.
I expect to have a lot of ups and downs during my recovery.

Past experiences with health care providers
Therapists cannot be trusted.
Most people I’ve seen don’t know how to help me with my problems.
I have not found going to therapy very helpful to me.
Therapists usually have their own agenda. They really aren’t interested in what I have to
say.
I have a hard time speaking up when I am dissatisfied with my treatment.

Concerns about possible side effects
I don’t know if I can handle my feelings if I talk about them in therapy.
I don’t always follow my doctor’s instructions because I am concerned about possible
side effects.
Taking medication will probably make me feel like a zombie.
I worry about becoming too dependent on my medication.

Determination that costs outweigh benefits
Therapy will probably only make things worse for me.
I can’t think of enough good reasons to stick with my outpatient treatment.
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I have more important things to do with my time other that going to my psychiatric
appointments.

Embarrassment about being in treatment
I am embarrassed about being in psychiatric treatment even though I know I need it.
I feel ashamed when I talk about my problems.
People will think I’m crazy if I tell them I am under psychiatric care.

Pessimism or skepticism about the effectiveness of treatment
I am very doubtful about how helpful treatment is likely to be for me.
I have little faith in ever getting better, no matter what kind of treatment I receive.
Nothing can ever help me.
My problems are always going to be there, whether or not I am in psychiatric treatment.

Impatience with the level of progress or the treatment process
I get frustrated with my lack of progress.
I don’t know if I can wait that long for things to start improving.
If things don’t change soon, then what’s the use?
If I didn’t feel better after a few appointments, I would probably stop going to treatment.

Competing demands that are deemed more important
I have more important things to do with my time other than going to therapy.
Going to treatment interferes with things that are more important to me.
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I don’t have the time that it takes to keep going to my treatment sessions.
I'm too busy to follow-up with aftercare. I've got a lot of other priorities that come first
like family, work and child care.

Paralysis of will
I don’t have the desire or motivation to stay in treatment.
It seems like I can’t motivate myself to do things that might help me, like going to
therapy or taking medication.
I stopped caring about going to treatment sessions.
I've been depressed for so long, there's nothing I can do about it.

Viewing treatment as interfering with future plans, relationships, self-concept or daily life
Going to treatment sessions will only get in the way of my plans.
I worry about people in my life knowing that I am in psychiatric treatment.
If I was a stronger person I wouldn’t need psychiatric care.
Following my doctor's orders means that I'm really not in control of my life. It's better to
do things my way.
People should learn to help themselves.
I am concerned that treatment will change me in ways that I don’t like or want.

Additional Items under Investigation

Unrealistic Optimism
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My discharge from this program means that I am fully recovered from my problems.
I feel better now, so I must be better. I don't need to do anything else like going to
appointments, taking medication, or doing self-help homework.
I don’t think I have to do anything else to stay healthy. I came to this program to get
better, now I am better.
All I have to do is to stay away from the wrong people and I'll be OK.

Hostility
Other people should get their act together before expecting me to do the same.
I can take care of my problems without other people telling me what to do.
If the staff did their job while I was here in the hospital, I wouldn't have to follow-up with
aftercare to keep myself healthy.
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Appendix B: Final Instrument
ZAHN-GIVEN RECOVERY BELIEFS QUESTIONNAIRE
Name: _______________________________

Date: ___________

Directions: This questionnaire consists of 20 statements. Please read each statement carefully. Circle
the number that best describes how strongly you believe each statement. Use the scoring key below
to indicate your response. Do not leave any statements blank.

HOW MUCH DO YOU BELIEVE
THIS STATEMENT?

Not at All

Slightly

Moderately

Very
Much

Totally

Does Not
Apply

1. I don’t think that treatment will help
me with my problems.

0

1

2

3

4

5

2. Having a mental illness means I’ll
never get better.

0

1

2

3

4

5

0

1

2

3

4

5

0

1

2

3

4

5

0

1

2

3

4

5

0

1

2

3

4

5

7. Taking medication will probably
make me feel like a zombie.

0

1

2

3

4

5

8. I worry about becoming too
dependent on my medication.

0

1

2

3

4

5

0

1

2

3

4

5

0

1

2

3

4

5

0

1

2

3

4

5

3. I have little faith in ever getting
better, no matter what kind of
treatment I receive.
4. Nothing can ever help me.
5. I’ve been depressed for so long,
there’s nothing I can do about it.
6. I might need to take psychiatric
medication even when I am feeling
better.

9. If I don’t feel better after a few
appointments, I’ll probably stop
going to treatment.
10. I have not found treatment helpful in
the past.
11. My discharge from this program
means that I am fully recovered from
my problems.
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HOW MUCH DO YOU BELIEVE
THIS STATEMENT?

Not at All

Slightly

Moderately

Very
Much

Totally

Does Not
Apply

0

1

2

3

4

5

0

1

2

3

4

5

0

1

2

3

4

5

0

1

2

3

4

5

16. People will think I’m crazy if I tell
them I am under psychiatric care.

0

1

2

3

4

5

17. I feel ashamed when I talk about my
problems.

0

1

2

3

4

5

0

1

2

3

4

5

0

1

2

3

4

5

0

1

2

3

4

5

12. I feel better now, so I must be better.
I don’t need to do anything else like
going to appointments, taking
medication, or doing self-help
homework.
13. All I have to do is stay away from
the wrong people and I’ll be OK.
14. I can take care of my problems
without other people telling me what
to do.
15. I am embarrassed about being in
treatment, even though I know I need
it.

18. I worry about people in my life
knowing that I am in psychiatric
treatment.
19. I don’t have the time that it takes to
keep going to my treatment sessions.
20. I’m too busy to follow-up with
aftercare. I’ve got a lot of other
priorities that come first like family,
work and childcare.
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Appendix C: Compliance with Treatment Form (Subject)
Section A
Please answer the following questions:
1. Have you taken any psychiatric medication (i.e., for mental health reasons) in the
past 6 months, or since your last hospitalization? _____Yes _____ No
1A. If no, has anyone ever recommended that you take psychiatric
medication? _____Yes _____ No
2. Have you seen a therapist or attended an outpatient program (e.g., partial hospital,
intensive outpatient program) within the past 6 months, or since your last
hospitalization? _____Yes (go to 2A) _____ No (go to 2B)
2A. If yes, did you complete the treatment?
_____Yes _____ No _____ Still in progress
2B. If no, has anyone recommended that you see a therapist or attend
an outpatient program? _____Yes _____ No
If you answered “yes” to question 1 or 2 proceed to Section B. If you answered
“no” to both 1 and 2 you are finished.
Section B
Instructions: Read each item carefully and select the number that best describes your
behavior in the past 6 months or since your last hospitalization. Please answer
honestly since your responses will in not negatively affect your current treatment.
Please use the following scale:
0 = does not apply
1 = totally agree
2 = agree somewhat
3 = neutral
4 = disagree somewhat
5 = totally disagree
_____
_____
_____
_____
_____
_____
_____

I consistently attend appointments with my outpatient psychiatrist.
I take my prescribed medication consistently and as directed by my doctor.
I forget to take my medication at times.
At times, I have taken more medication than what was prescribed for me.
At times I have taken less medication than what was prescribed for me.
I attend appointments with my therapist and/or program on a regular basis.
I have dropped out of treatment before completing it.

Appendix D: Compliance with Treatment Form (Clinician)
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Section A
Please answer the following questions:
1. Has the patient taken any psychiatric medication in the past 6 months, or since
their last hospitalization? _____Yes _____ No
1A. If no, has anyone ever recommended that the patient take
psychiatric medication? _____Yes _____ No
2. Has the patient seen a therapist or attended an outpatient program (e.g., partial
hospital, intensive outpatient program) within the past 6 months, or since their
last hospitalization? _____Yes (go to 2A) _____ No (go to 2B)
2A. If yes, did they complete the treatment?
_____Yes _____ No _____ Still in progress
2B. If no, has anyone recommended that that the patient see a therapist
or attend an outpatient program? _____Yes _____ No
If you answered “yes” to question 1 or 2 proceed to Section B. If you answered
“no” to both 1 and 2 you are finished.
Section B
Instructions: Please select the number that best describes your patient’s behavior in the past
6 months or since their last hospitalization using the following scale:
0 = does not apply
1 = totally agree
2 = agree somewhat
3 = neutral
4 = disagree somewhat
5 = totally disagree
_____ The patient is consistent in attending appointments with his/her outpatient
psychiatrist.
_____ The patient takes prescribed medication consistently and as directed.
_____ The patient forgets to take medication at times.
_____ The patient sometimes takes more medication than what is prescribed.
_____ The patient sometimes takes less medication than what is prescribed.
_____ The patient attends appointments with his/her outpatient therapist and/or
program on a regular basis.
_____ The patient drops out of treatment before completion.

